SARATOGA SPRINGS, NY, April 20, 2011--The war on drugs, Thoroughbred racing style, has begun in earnest. Let’s hope that racing’s initiative will be a lot more successful than the government’s have been in this spot.

In this case, we’re not referencing drugs euphemistically called “juice,” “rocket fuel,” “hop,” or any other name one cares to attach to it.

Rather, it’s the continued use of legal raceday medication that will have an equally profound effect on how the industry is shown to treat the animals in its care, as well as the customers who make the entire exercise possible.

The recent announcement by the Association of Racing Commissioners International, the first major industry organization calling for an end to the use of legal raceday medications furosemide, phenylbutazone or any of its “adjuncts” within five years, is a positive first step.

Furosemide, a.k.a. Lasix, has been proven to be a sword that cuts both ways. There are studies showing it reduces the number of runners suffering from exercise induced pulmonary hemorrhaging (EIPH), but there are others indicating that horses racing on Lasix run faster than those that do not.

If the latter finding doesn’t underscore the theory that Lasix also serves to purge illegal substances from a horse’s system faster, or work as a masking agent when combined with certain illegal substances, nothing does. In either case, that notion is hard to reconcile.

Lasix was originally intended for horses which upon examination were found to have bled. Now, all trainers seem to need is a note from their friendly veterinarian indicating trace amounts found after a morning workout. Otherwise, how can so many first-time-starting two year olds debut on the diuretic?

Lasix use has more than doubled in the past two decades. According to Jockey Club research, nine of every 10 racehorses run on Lasix each day.

The RCI initiative immediately drew support from the Jockey Club, which if it wanted could end raceday medication unilaterally and immediately. As keepers of the American Stud Book, it simply could refuse to register any foal whose parents ran on raceday medication. But this issue is bigger than Jockey Club sanctions, even if the organization is “dedicated to the improvement of Thoroughbred breeding and racing.”

The Jockey Club announcement was followed in rapid succession by other prominent organizations: Breeders’ Cup Ltd., Thoroughbred Racing Associations, Thoroughbred Owners and Breeders’ Association (including its Graded Stakes Committee), Kentucky Thoroughbred Association and the Kentucky Thoroughbred Owners and Breeders. All have pledged their support.

Churchill Downs Inc. also issued a statement welcoming discussion on the issue. While talk is a cheap commodity, at least the company is following the lead of horsemen’s groups within the Commonwealth.

Sadly, this issue has been “discussed” industry wide for the last four decades but status quo has remained the order of the day.

No such publicly stated willingness has taken place in other leading jurisdictions thus far, those in California, Florida and New York. The New York Racing Association, the perceived industry leader, has been mum, perhaps owing to the wishes of the New York Thoroughbred Horsemen’s Association whose current leadership is philosophically pro-Lasix.

Despite the fact TOBA is a founding member of the National Thoroughbred Racing Association, the NTRA has yet to issue a position on the RCI proposal, choosing instead to hold a wet index finger in the air to measure the velocity of prevailing winds. The NTRA lost badly needed economic support last year and cannot survive more defections from its ranks.

It must be acknowledged that veterinarians have a financial incentive to provide raceday medication, and a trainer's job is made easier via the administration of Lasix and Bute, a pain killer, somewhat easing the financial burden on owners to keep horses in training instead giving them what they occasionally need: Time, and time is money.

Current realities, both aesthetic and economic, synch perfectly with the stance taken by the National Horsemen’s Benevolent and Protective Association in which, among other things, it defended Lasix as little more than a beneficial, therapeutic medication.

“These issues are not as black and white as some would have us believe,” stated the NHBPA in a press release. “It is vital that we balance the needs of effective regulation with sensible practices that benefit the horse.” Of course, this makes perfect sense, except for the part about benefiting the horse.

Worse was its appalling and hypocritical conclusion to their position paper: “Let’s step back from the ‘shock and awe’ tactics and focus on policies that are in the best long-term interest of the racehorses and the owners, trainers, jockeys, grooms and exercise riders who care for them each day.”

The use of raceday medication going forward not only will have a direct effect on racing’s survival but to what extent it will prosper in the future. And nowhere is the plight of the betting public and fans of Thoroughbred racing considered. This begs several questions, to wit:

How many bettors have walked away from the game because they don’t believe the playing field is level for all? How many in the last decade walked away in the aftermath of the very public Barbaro and Eight Belles tragedies?

How can so many of the game’s practitioners fail to see that what they accept as “unfortunate accidents that are part of the game” is unacceptable to an unknowing and unsophisticated populace?

Do so many horsemen wear closed-cup blinkers that they cannot see “taking a bad step” is nothing more or nothing less than animal cruelty in the public’s eye, a public that could shut the whole down thing down because for 15 minutes they were empowered to take action and feel good about themselves?

What if, tragically, a Kentucky Derby contender takes a bad step from which it will never recover? How many more bad steps will the general public tolerate before it demands that federal, state, or local governments padlock the gates of racetracks everywhere?

Although the RCI means well, five years is too long to wait, but 2012 is not a practical time frame either. Shouldn’t every responsible organization admit to themselves that the public, unaware of racing’s glorious past, resents medication in all sports, legal and otherwise?

While a real fix may be somewhere off in the near future, now is the time for racing to admit they’re aware of how society perceives the industry. Be proactive. Ask NBC Sports for a segment on its Derby Day telecast to admit that racing, just like other sports and society as a whole, has a drug problem.

Show the viewing public that Thoroughbred racing cares, that it’s aware of the problem and is taking steps to deal with medication issues real and imagined. And explain why this all can’t be done in time for the Preakness.

Tell them that if racing doesn‘t get its act together the Jockey Club will deny registration to foals whose sire and dam ran raced legal medication and not allowed to race, or how the Graded Stakes Committee could make stallions and dams less valuable in the marketplace by denying graded status to stakes winners competing on medication.

Show the public how you intend to get serious about dealing with the medication issue. Or continue to do nothing and live with the consequences. There is always a reckoning. Have you noted the continuing decline in attendance, handle and breeding values?

Collectively look at the numbers then try to rationalize it by convincing yourself otherwise. Intended or not, the RCI initiative sounded a clarion call. Ignore it at your peril, if not tomorrow then the day after. Business as usual is running out of racetrack, and fast.

Tomorrow: A Few Practical Suggestions